Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease

Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease, which is associated with an increased risk of cardiovascular disease (CVD). Metabolic syndrome (MetS) is a set of factors that increase the risk of CVD, and recent studies suggested an increased prevalence of MetS in RA more th...

Full description

Bibliographic Details
Main Authors: Rawdha Tekaya, Leila Rouached, Habib Ben Ahmed, Aicha Ben Tekaya, Kahena Bouzid, Selma Bouden, Olfa Saidane, Ines Mahmoud, Leila Abdelmoula
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=4;spage=359;epage=363;aulast=Tekaya
_version_ 1797954992067313664
author Rawdha Tekaya
Leila Rouached
Habib Ben Ahmed
Aicha Ben Tekaya
Kahena Bouzid
Selma Bouden
Olfa Saidane
Ines Mahmoud
Leila Abdelmoula
author_facet Rawdha Tekaya
Leila Rouached
Habib Ben Ahmed
Aicha Ben Tekaya
Kahena Bouzid
Selma Bouden
Olfa Saidane
Ines Mahmoud
Leila Abdelmoula
author_sort Rawdha Tekaya
collection DOAJ
description Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease, which is associated with an increased risk of cardiovascular disease (CVD). Metabolic syndrome (MetS) is a set of factors that increase the risk of CVD, and recent studies suggested an increased prevalence of MetS in RA more than in general population. Aim: The aim of this study is to determine the prevalence of MetS in patients with RA and to evaluate its association with the disease activity and inflammation parameters. Then, to evaluate other cardiovascular risk factor and HeartSCORE Eular 2015 and its relation with the MetS. Methods: It is a cross-sectional study of 103 RA patients assessing the prevalence of the MetS in RA patients. MetS was defined according to the National Cholesterol Education Program/Adult Treatment Panel III guidelines. RA disease activity was assessed with CDAI, SDAI and DAS28 scores. Independent risk factors for MetS in RA patients were identified by logistic regression. Results: The mean age was 53 ± 10 years. The sex ratio (Male/female) was 0.3. About half of patients (45%) had moderate disease activity with a mean DAS28 CRP score of 3.9±1.38. Prevalence of MetS was 38.8% in RA patients. MetS was associated with higher age (P=0.03), late onset disease age (P=0.01), family history of CVD (P=0.016), current use of corticoid (P=0.01) and menopause status (P=0.006). However disease activity, inflammation or treatment were not associated with MetS. Conclusions: MetS in RA patients was not associated with inflammation and disease activity.
first_indexed 2024-04-10T23:26:19Z
format Article
id doaj.art-5a21864bba0743b4b0020263e22e599a
institution Directory Open Access Journal
issn 0973-3698
0973-3701
language English
last_indexed 2024-04-10T23:26:19Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Rheumatology
spelling doaj.art-5a21864bba0743b4b0020263e22e599a2023-01-12T12:10:18ZengWolters Kluwer Medknow PublicationsIndian Journal of Rheumatology0973-36980973-37012022-01-0117435936310.4103/injr.injr_122_21Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with diseaseRawdha TekayaLeila RouachedHabib Ben AhmedAicha Ben TekayaKahena BouzidSelma BoudenOlfa SaidaneInes MahmoudLeila AbdelmoulaBackground: Rheumatoid arthritis (RA) is a chronic inflammatory disease, which is associated with an increased risk of cardiovascular disease (CVD). Metabolic syndrome (MetS) is a set of factors that increase the risk of CVD, and recent studies suggested an increased prevalence of MetS in RA more than in general population. Aim: The aim of this study is to determine the prevalence of MetS in patients with RA and to evaluate its association with the disease activity and inflammation parameters. Then, to evaluate other cardiovascular risk factor and HeartSCORE Eular 2015 and its relation with the MetS. Methods: It is a cross-sectional study of 103 RA patients assessing the prevalence of the MetS in RA patients. MetS was defined according to the National Cholesterol Education Program/Adult Treatment Panel III guidelines. RA disease activity was assessed with CDAI, SDAI and DAS28 scores. Independent risk factors for MetS in RA patients were identified by logistic regression. Results: The mean age was 53 ± 10 years. The sex ratio (Male/female) was 0.3. About half of patients (45%) had moderate disease activity with a mean DAS28 CRP score of 3.9±1.38. Prevalence of MetS was 38.8% in RA patients. MetS was associated with higher age (P=0.03), late onset disease age (P=0.01), family history of CVD (P=0.016), current use of corticoid (P=0.01) and menopause status (P=0.006). However disease activity, inflammation or treatment were not associated with MetS. Conclusions: MetS in RA patients was not associated with inflammation and disease activity.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=4;spage=359;epage=363;aulast=Tekayadisease activitymetabolic syndromerheumatoid arthritis
spellingShingle Rawdha Tekaya
Leila Rouached
Habib Ben Ahmed
Aicha Ben Tekaya
Kahena Bouzid
Selma Bouden
Olfa Saidane
Ines Mahmoud
Leila Abdelmoula
Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease
Indian Journal of Rheumatology
disease activity
metabolic syndrome
rheumatoid arthritis
title Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease
title_full Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease
title_fullStr Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease
title_full_unstemmed Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease
title_short Prevalence of metabolic syndrome in rheumatoid arthritis patients: Association with disease
title_sort prevalence of metabolic syndrome in rheumatoid arthritis patients association with disease
topic disease activity
metabolic syndrome
rheumatoid arthritis
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=4;spage=359;epage=363;aulast=Tekaya
work_keys_str_mv AT rawdhatekaya prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT leilarouached prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT habibbenahmed prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT aichabentekaya prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT kahenabouzid prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT selmabouden prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT olfasaidane prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT inesmahmoud prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease
AT leilaabdelmoula prevalenceofmetabolicsyndromeinrheumatoidarthritispatientsassociationwithdisease